Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.70 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.70 |
| ▸ | TDP1 | Q9NUW8 | 4/20 | 0.67 |
| ▸ | ATM | Q13315 | 1/20 | 0.67 |
| ▸ | GPR35 | Q9HC97 | 2/20 | 0.59 |
| ▸ | TSHR | P16473 | 3/20 | 0.53 |
| ▸ | TP53 | P04637 | 1/20 | 0.53 |
| ▸ | HPGD | P15428 | 1/20 | 0.53 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.53 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.53 |
| ▸ | TXNRD1 | Q16881 | 1/20 | 0.52 |
| ▸ | TXNRD3 | Q86VQ6 | 1/20 | 0.52 |
| ▸ | TXNRD2 | Q9NNW7 | 1/20 | 0.52 |
| ▸ | HSPB1 | P04792 | 3/20 | 0.51 |
| ▸ | LMNA | P02545 | 1/20 | 0.48 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.47 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.47 |
| ▸ | VCAM1 | P19320 | 1/20 | 0.46 |
| ▸ | PTPRC | P08575 | 1/20 | 0.45 |
| ▸ | S100A4 | P26447 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31474855 | 1.00 | ALDH1A1 (0.70) | ALDH1A1HIF1ATDP1ATMGPR35 | |
| Formic Acid SCHEMBL28202419 | 0.91 | ALDH1A1 (0.59) | ALDH1A1HIF1ATDP1ATMGPR35 | |
| SCHEMBL27739457 | 0.88 | TDP1 (0.73) | ALDH1A1HIF1ATDP1ATMGPR35 | |
| SCHEMBL35276 | 0.83 | ALDH1A1 (1.00) | ALDH1A1HIF1ATDP1ATMGPR35 | |
| SCHEMBL27715742 | 0.83 | ALDH1A1 (1.00) | ALDH1A1HIF1ATDP1ATMGPR35 | |
| SCHEMBL29349904 | 0.83 | ALDH1A1 (1.00) | ALDH1A1HIF1ATDP1ATMGPR35 | |
| SCHEMBL29379039 | 0.82 | ALDH1A1 (0.69) | ALDH1A1HIF1ATDP1GPR35TSHR | |
| SCHEMBL85604 | 0.82 | ALDH1A1 (0.69) | ALDH1A1HIF1ATDP1GPR35TSHR | |
| SCHEMBL28252591 | 0.82 | ALDH1A1 (0.69) | ALDH1A1HIF1ATDP1GPR35TSHR | |
| SCHEMBL28309178 | 0.81 | ALDH1A1 (0.96) | ALDH1A1HIF1ATDP1ATMGPR35 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 42 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-110527092-A | A method of preparing high molecular weight poly arylidene thio-ester sulfone | ZHUHAI CHANGXIAN NEW MATERIALS TECH CO LTD | 2019-12-03 | — | — | CN | claimed |
| CN-105621587-B | A kind of method using potentiometric titrations degradating chloro nitro-aromatic | 浙江大学 | 2018-01-23 | — | — | CN | claimed |
| US-20250250240-A1 | PHENAZINE COMPOUND FOR MEASURING BACTERIAL EFFLUX | UNIVERSITE D'AIX-MARSEILLE (FR) | 2025-08-07 | — | — | US | disclosed |
| EP-4466254-A1 | PHENAZINE COMPOUND FOR MEASURING BACTERIAL EFFLUX | Université d'Aix Marseille (FR) | 2024-11-27 | — | — | EP | disclosed |
| WO-2023139263-A1 | PHENAZINE COMPOUND FOR MEASURING BACTERIAL EFFLUX | UNIVERSITE D'AIX-MARSEILLE (FR) | 2023-07-27 | — | — | WO | disclosed |
| CN-112812711-B | High-reactivity metal-rubber hot vulcanization adhesive and application method thereof | 安徽普力通新材料科技有限公司 | 2023-07-18 | — | — | CN | disclosed |
| CN-112023046-B | Application of miR-2115in diagnosis and treatment of atopic dermatitis | 河北仁博科技有限公司 | 2022-05-10 | — | — | CN | disclosed |
| CN-112094895-B | MiRNA for diagnosis and treatment of atopic dermatitis | 河北仁博科技有限公司 | 2021-08-13 | — | — | CN | disclosed |
| CN-112812711-A | High-reactivity metal-rubber heat-vulcanization adhesive and using method thereof | 安徽普力通新材料科技有限公司 | 2021-05-18 | — | — | CN | disclosed |
| CN-112094895-A | MiRNA for diagnosis and treatment of atopic dermatitis | 河北仁博科技有限公司 | 2020-12-18 | — | — | CN | disclosed |
| CN-112023046-A | Application of miR-2115in diagnosis and treatment of atopic dermatitis | 河北仁博科技有限公司 | 2020-12-04 | — | — | CN | disclosed |
| US-6329344-B1 | UREA DERIVATIVE OF ALKYLENE DIOXYFURAN ETHERS | RANBAXY LABORATORIES LIMITED (IN) | 2001-12-11 | — | — | US | disclosed |
| EP-1144425-A1 | DERIVATIVES OF MONOSACCHARIDES AS CELL ADHESION INHIBITORS | RANBAXY LABORATORIES, LTD. (IN) | 2001-10-17 | — | — | EP | disclosed |
| US-6242654-B1 | REACTING A PHENOLATE COMPOUND WITH AN ORGANIC FLUORINATING AGENT TO PREPARE A FLUORINE SUBSTITUTED AROMATIC COMPOUND | MITSUI CHEMICALS, INC. (JP) | 2001-06-05 | — | — | US | disclosed |
| WO-2000042053-A1 | DERIVATIVES OF MONOSACCHARIDES AS CELL ADHESION INHIBITORS | RANBAXY LABORATORIES LIMITED (US) | 2000-07-20 | — | — | WO | disclosed |
| EP-1013629-A1 | Preparation process of fluorine subsituted aromatic compound | Mitsui Chemicals, Inc. (JP) | 2000-06-28 | — | — | EP | disclosed |
| EP-0270964-B1 | PROCESS FOR OBTAINING SUBSTITUTED FLUOROBENZENES | BAYER AG (DE) | 1992-07-08 | — | — | EP | disclosed |
| US-4868347-A | SOLVENT EXTRACTION | BAYER AKTIENGESELLSCHAFT (DE) | 1989-09-19 | — | — | US | disclosed |
| EP-0270964-A2 | Process for obtaining substituted fluorobenzenes | BAYER AG (DE) | 1988-06-15 | — | — | EP | disclosed |
| EP-0237899-A1 | Production of fluoroaniline derivatives | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 1987-09-23 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250250240-A1 | PHENAZINE COMPOUND FOR MEASURING BACTERIAL EFFLUX | ABCC5, ABCB11, TMEM165 | ALDH1A1 2835/4885HIF1A 2516/4885TDP1 3746/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.